AT278 and NovoRapid® in Glucose Clamp Study (Q105789486)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AT278 and NovoRapid® in Glucose Clamp Study |
clinical trial |
Statements
Phase 1 Single Dose, Randomised, Double-blind, Two-way Crossover, Glucose Clamp Study Investigating the Pharmacodynamics, Pharmacokinetics and Safety of Arecor Rapid-acting Concentrated Insulin Aspart (AT278) in Comparison to Insulin Aspart NovoRapid® in Participants With Type 1 Diabetes Mellitus (T1DM). (English)
0 references
2 December 2020
0 references
June 2021
0 references
38
0 references
18 year
0 references
64 year
0 references